CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease

Journal of Investigative Dermatology

Volumn 134, Issue 6, 2014, Pages 1552-1560

  Villarroel, Vadim A ^a   Okiyama, Naoko ^a   Tsuji, Gaku ^a   Linton, Jay T ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME INACTIVATION; EPIDERMIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT VERSUS HOST REACTION; HISTOLOGY; IMMUNOPATHOGENESIS; KERATINOCYTE; LYMPH NODE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PATHOGENICITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SKIN INFILTRATE; T LYMPHOCYTE ACTIVATION; WILD TYPE; CELL HOMING; GENE TARGETING; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SKIN DISEASE; SPLEEN;

ANIMALS; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL SEPARATION; CHEMOKINE CXCL10; CHEMOKINE CXCL9; EPIDERMIS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; KERATIN-14; LIGANDS; LYMPH NODES; LYMPHOCYTES; MICE; MICE, KNOCKOUT; OVALBUMIN; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR3; SKIN; T-LYMPHOCYTES; UP-REGULATION;

EID: 84900873375     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.2     Document Type: Article

References (35)

1. Belperio JA, Keane MP, Burdick MD et al. (2003) Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 171:4844-52
2. Duffner U, Lu B, Hildebrandt GC et al. (2003) Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 31:897-902
3. Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-402
4. Frigerio S, Junt T, Lu B (2002) Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8:1414-20
5. Groom JR, Luster AD (2011) CXCR3 in T cell function. Exp Cell Res 317: 620-31
6. He S, Cao Q, Qiu Y et al. (2008) A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody. J Immunol 181: 7581-92
7. Hildebrandt GC, Corrion LA, Olkiewicz KM et al. (2004) Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol 173:2050-9
8. Hong M, Puaux AL, Huang C et al. (2011) Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. Cancer Res 71:6997-7009
9. Ito T, Hashizume H, Shimauchi T et al. (2013) CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. J Dermatol Sci 69:140-7
10. Jenh CH, Cox MA, Cui L et al. (2012) A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol 13:2
11. Kim BS, Miyagawa F, Cho YH et al. (2009) Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol 129:2805-17
12. Laragione T, Brenner M, Sherry B et al. (2011) CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis. Arthritis Rheum 63:3274-83
13. Ley K, Kansas GS (2004) Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 4:325-35
14. Li B, Xu W, Xu L et al. (2010) I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft. Cell Immunol 260:83-91
15. Lonsdorf AS, Hwang ST, Enk AH (2009) Chemokine receptors in T-cellmediated diseases of the skin. J Invest Dermatol 129:2552-66
16. McPhee CG, Duncan FJ, Silva KA et al. (2012) Increased expression of Cxcr3 and its ligands, CXCL9, and CXCL10, during the development of alopecia areata in the mouse. J Invest Dermatol 132:1736-8
17. Melter M, Exeni A, Reinders ME et al. (2001) Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104:2558-64
18. Miyagawa F, Tagaya Y, Kim BS et al. (2008) IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol 181: 1109-19
19. Mu llegger RR, Means TK, Shin JJ et al. (2007) Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun 75:4621-8
20. Norii M, Yamamura M, Iwahashi M et al. (2006) Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis. Acta Med Okayama 60:149-57
21. Okiyama N, Furumoto Y, Villarroel VA et al. (2014) Reversal of CD8 T cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor, Tofacitinib. J Invest Dermatol; doi:10.1038/jid.2013.476
22. Piper KP, Horlock C, Curnow SJ et al. (2007) CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood 110:3827-32
23. Qin S, Rottman JB, Myers P et al. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-54
24. Reshef R, Luger SM, Hexner EO et al. (2012) Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med 367:135-45
25. Rosas LE, Barbi J, Lu B et al. (2005) CXCR3-/-mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur J Immunol 35:515-23
26. Schroeder MA, DiPersio JF (2011) Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech 4:318-33
27. Shibaki A, Sato A, Vogel JC et al. (2004) Induction of GvHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol 123:109-15
28. Suga H, Sugaya M, Miyagaki T et al. (2013) CXCR3 deficiency prolongs Th1-type contact hypersensitivity. J Immunol 190:6059-70
29. Sugerman PB, Faber SB, Willis LM et al. (2004) Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol 164:2189-202
30. Taqueti VR, Grabie N, Colvin R et al. (2006) T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. J Immunol 177:5890-901
31. Wenzel J, Tu ting T (2008) An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in interface dermatitis. J Invest Dermatol 128:2392-402
32. Wenzel J, Lucas S, Zahn S et al. (2008) CXCR3 o-4 ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease. J Am Acad Dermatol 58:437-42
33. Wijtmans M, Verzijl D, Leurs R et al. (2008) Towards small-molecule CXCR3 ligands with clinical potential. Chem Med Chem 3:861-72
34. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR et al. (2005) Leukocyte migration and graft-versus-host disease. Blood 105:4191-9
35. Yang YG, Wang H, Asavaroengchai W et al. (2005) Role of interferon-gamma in GvHD and GVL. Cell Mol Immunol 2:323-9